Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.biomaterials.2013.06.010
Title: Development of a gene/drug dual delivery system for brain tumor therapy: Potent inhibition via RNA interference and synergistic effects
Authors: Lei, C.
Cui, Y.
Zheng, L.
Kah-Hoe Chow, P.
Wang, C.-H. 
Keywords: Drug/gene delivery
Intracranial glioblastoma
Microfiber
MMPs
RNA interference
Issue Date: Oct-2013
Citation: Lei, C., Cui, Y., Zheng, L., Kah-Hoe Chow, P., Wang, C.-H. (2013-10). Development of a gene/drug dual delivery system for brain tumor therapy: Potent inhibition via RNA interference and synergistic effects. Biomaterials 34 (30) : 7483-7494. ScholarBank@NUS Repository. https://doi.org/10.1016/j.biomaterials.2013.06.010
Abstract: Malignant brain tumors are characterized by three major physiological processes: proliferation, angiogenesis, and invasion. Traditional cytotoxic chemotherapies (e.g. Paclitaxel) control the tumor by blocking growth and proliferation mechanisms, but leave angiogenesis and invasion unchecked. We identified Matrix metalloproteinase-2 (MMP-2), an essential proteinase regulating brain tumor invasion and angiogenesis, as one of the therapeutic target. A designer RNAi plasmid was developed, and complexed with the gene carrier polyethylenimine (PEI), in an effort to specifically suppress MMP-2 expression in tumor cells. The gene and a cytotoxic drug Paclitaxel were then dual-encapsulated in PLGA based submicron implants to achieve a sustained release of both agents. Potent inhibition effects on MMP-2 mRNA and protein expression, invitro cell angiogenesis and invasion were demonstrated both on the PEI/DNA nanoparticles alone, and on the PEI/DNA nanoparticles embedded in microfibers. Most importantly, through invivo test on intracranial xenograft tumor model in BALB/c nude mice, it was proved that the gene/drug dual delivery microfibers are able to impose significant tumor regression compared with single drug delivery microfibers and commercial drug treatment, showing evidence for synergistic therapeutic efficacy. © 2013 Elsevier Ltd.
Source Title: Biomaterials
URI: http://scholarbank.nus.edu.sg/handle/10635/88756
ISSN: 01429612
DOI: 10.1016/j.biomaterials.2013.06.010
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

33
checked on Dec 12, 2018

WEB OF SCIENCETM
Citations

31
checked on Dec 12, 2018

Page view(s)

48
checked on Dec 7, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.